Advances in artificial intelligence for brain imaging and computer-aided diagnosis of neurological diseases: a systematic literature review.
- 1School of Digital Technologies, Narxoz University, Almaty, Kazakhstan.
- 2Department of Mathematical and Computer Modeling, International Information Technology University, Almaty, Kazakhstan.
- 3Department of Software Engineering, Faculty of Physics, Mathematics and Information Technology, Khalel Dosmukhamedov Atyrau University, Atyrau, Kazakhstan.
Abstract
Brain imaging is central to the structural, functional, metabolic, and neurophysiological characterization of neurological disease, yet interpretation remains constrained by heterogeneity in acquisition, annotation, expertise, and clinical context. This systematic literature review evaluates recent artificial intelligence approaches for brain imaging and computer-aided diagnosis, with emphasis on methods, modalities, neurological diseases, diagnostic tasks, datasets, validation practices, and translational limitations. The review followed PRISMA 2020 and covered peer-reviewed English-language studies published from January 2020 through June 2026. Eight information sources were searched using database-specific terms for artificial intelligence, neuroimaging, neurological disease, and diagnostic analysis. The search identified 1,078 records; 236 duplicates were removed, 842 unique records were screened, 258 full texts were assessed, and 123 studies were included after a record-level eligibility re-audit. Heterogeneous evidence was synthesized narratively and by descriptive mapping rather than meta-analysis. MRI was frequently represented in the included studies and auxiliary mapping data; CT was commonly used in acute stroke and intracranial hemorrhage; PET supported selected molecular and differential-diagnosis studies; fMRI and diffusion imaging were used for network and white-matter analysis; and EEG extended the scope to neurophysiological diagnosis. CNN and three-dimensional networks were commonly reported, while attention, Transformer, graph, self-supervised, generative, multimodal, and foundation-model approaches appeared in selected recent studies. Stroke, dementia, and brain tumors were frequently represented, but heterogeneous populations, outcomes, and incomplete validation extraction precluded ranking diseases, modalities, architectures, or validation strategies. The evidence suggests movement from task-specific pattern recognition toward multimodal and context-rich decision support in selected settings, but it does not establish uniform methodological superiority or clinical maturity. Dependable translation requires patient-level data governance, transparent reporting, uncertainty estimation, independent multicenter testing, prospective workflow evaluation, and clinically meaningful endpoints.
Related
- Generative Artificial Intelligence Models in Breast Cancer Diagnosis: A Systematic Review
- Artificial intelligence (AI) in melanocytic lesions diagnosis: a systematic review of methods incorporating ABCD(E)-derived features
- Artificial Intelligence in Eye Disease: A Systematic Review of Screening, Diagnosis, Prognosis, Treatment-Response Prediction, and Clinical Decision Support
- Artificial intelligence empowering the diagnosis and treatment of rotator cuff tears: A systematic review from image optimization to prognosis prediction.
- Diagnostic accuracy of tongue diagnosis for stroke syndrome differentiation in traditional Chinese medicine: a systematic review, meta-analysis, and narrative synthesis of artificial intelligence-assisted models.
BibTeX
@article{omarov2026advances,
title = {{Advances in artificial intelligence for brain imaging and computer-aided diagnosis of neurological diseases: a systematic literature review.}},
author = {Batyrkhan Omarov},
journal = {Frontiers in human neuroscience},
year = {2026},
month = oct,
doi = {10.3389/fnhum.2026.1963855},
url = {https://europepmc.org/article/MED/42952994},
note = {CC BY},
}
RIS
TY - JOUR
TI - Advances in artificial intelligence for brain imaging and computer-aided diagnosis of neurological diseases: a systematic literature review.
AU - Batyrkhan Omarov
PY - 2026
DA - 2026/10/14
JO - Frontiers in human neuroscience
DO - 10.3389/fnhum.2026.1963855
UR - https://europepmc.org/article/MED/42952994
AB - Brain imaging is central to the structural, functional, metabolic, and neurophysiological characterization of neurological disease, yet interpretation remains constrained by heterogeneity in acquisition, annotation, expertise, and clinical context. This systematic literature review evaluates recent artificial intelligence approaches for brain imaging and computer-aided diagnosis, with emphasis on methods, modalities, neurological diseases, diagnostic tasks, datasets, validation practices, and translational limitations. The review followed PRISMA 2020 and covered peer-reviewed English-language studies published from January 2020 through June 2026. Eight information sources were searched using database-specific terms for artificial intelligence, neuroimaging, neurological disease, and diagnostic analysis. The search identified 1,078 records; 236 duplicates were removed, 842 unique records were screened, 258 full texts were assessed, and 123 studies were included after a record-level eligibility re-audit. Heterogeneous evidence was synthesized narratively and by descriptive mapping rather than meta-analysis. MRI was frequently represented in the included studies and auxiliary mapping data; CT was commonly used in acute stroke and intracranial hemorrhage; PET supported selected molecular and differential-diagnosis studies; fMRI and diffusion imaging were used for network and white-matter analysis; and EEG extended the scope to neurophysiological diagnosis. CNN and three-dimensional networks were commonly reported, while attention, Transformer, graph, self-supervised, generative, multimodal, and foundation-model approaches appeared in selected recent studies. Stroke, dementia, and brain tumors were frequently represented, but heterogeneous populations, outcomes, and incomplete validation extraction precluded ranking diseases, modalities, architectures, or validation strategies. The evidence suggests movement from task-specific pattern recognition toward multimodal and context-rich decision support in selected settings, but it does not establish uniform methodological superiority or clinical maturity. Dependable translation requires patient-level data governance, transparent reporting, uncertainty estimation, independent multicenter testing, prospective workflow evaluation, and clinically meaningful endpoints.
SN - 1662-5161
ER -